Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth - PubMed (original) (raw)
. 2001 Nov;7(11):1194-201.
doi: 10.1038/nm1101-1194.
K Hattori, S Dias, C Costa, P Blaikie, L Butros, A Chadburn, B Heissig, W Marks, L Witte, Y Wu, D Hicklin, Z Zhu, N R Hackett, R G Crystal, M A Moore, K A Hajjar, K Manova, R Benezra, S Rafii
Affiliations
- PMID: 11689883
- DOI: 10.1038/nm1101-1194
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
D Lyden et al. Nat Med. 2001 Nov.
Abstract
The role of bone marrow (BM)-derived precursor cells in tumor angiogenesis is not known. We demonstrate here that tumor angiogenesis is associated with recruitment of hematopoietic and circulating endothelial precursor cells (CEPs). We used the angiogenic defective, tumor resistant Id-mutant mice to show that transplantation of wild-type BM or vascular endothelial growth factor (VEGF)-mobilized stem cells restore tumor angiogenesis and growth. We detected donor-derived CEPs throughout the neovessels of tumors and Matrigel-plugs in an Id1+/-Id3-/- host, which were associated with VEGF-receptor-1-positive (VEGFR1+) myeloid cells. The angiogenic defect in Id-mutant mice was due to impaired VEGF-driven mobilization of VEGFR2+ CEPs and impaired proliferation and incorporation of VEGFR1+ cells. Although targeting of either VEGFR1 or VEGFR2 alone partially blocks the growth of tumors, inhibition of both VEGFR1 and VEGFR2 was necessary to completely ablate tumor growth. These data demonstrate that recruitment of VEGF-responsive BM-derived precursors is necessary and sufficient for tumor angiogenesis and suggest new clinical strategies to block tumor growth.
Similar articles
- Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
Li H, Gerald WL, Benezra R. Li H, et al. Cancer Res. 2004 Sep 1;64(17):6137-43. doi: 10.1158/0008-5472.CAN-04-1287. Cancer Res. 2004. PMID: 15342397 - The Id proteins and angiogenesis.
Benezra R, Rafii S, Lyden D. Benezra R, et al. Oncogene. 2001 Dec 20;20(58):8334-41. doi: 10.1038/sj.onc.1205160. Oncogene. 2001. PMID: 11840326 Review. - A genetic approach to understanding tumor angiogenesis.
Benezra R, de Candia P, Li H, Romero E, Lyden D, Rafii S, Ruzinova M. Benezra R, et al. Cold Spring Harb Symp Quant Biol. 2002;67:249-54. doi: 10.1101/sqb.2002.67.249. Cold Spring Harb Symp Quant Biol. 2002. PMID: 12858547 No abstract available. - Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.
Hattori K, Dias S, Heissig B, Hackett NR, Lyden D, Tateno M, Hicklin DJ, Zhu Z, Witte L, Crystal RG, Moore MA, Rafii S. Hattori K, et al. J Exp Med. 2001 May 7;193(9):1005-14. doi: 10.1084/jem.193.9.1005. J Exp Med. 2001. PMID: 11342585 Free PMC article. - Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M, Seetharam L, Ishii Y, Sawano A, Gotoh N, Matsushime H, Yamaguchi S. Shibuya M, et al. Princess Takamatsu Symp. 1994;24:162-70. Princess Takamatsu Symp. 1994. PMID: 8983073 Review.
Cited by
- The complexity of immune evasion mechanisms throughout the metastatic cascade.
Haynes NM, Chadwick TB, Parker BS. Haynes NM, et al. Nat Immunol. 2024 Oct;25(10):1793-1808. doi: 10.1038/s41590-024-01960-4. Epub 2024 Sep 16. Nat Immunol. 2024. PMID: 39285252 Review. - Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications-A Narrative Review.
Todor SB, Ichim C, Boicean A, Mihaila RG. Todor SB, et al. Curr Issues Mol Biol. 2024 Aug 2;46(8):8407-8423. doi: 10.3390/cimb46080496. Curr Issues Mol Biol. 2024. PMID: 39194713 Free PMC article. Review. - The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis.
Calderon-Espinosa E, De Ridder K, Benoot T, Jansen Y, Vanhonacker D, Heestermans R, De Becker A, Van Riet I, Decoster L, Goyvaerts C. Calderon-Espinosa E, et al. Front Immunol. 2024 Aug 1;15:1397469. doi: 10.3389/fimmu.2024.1397469. eCollection 2024. Front Immunol. 2024. PMID: 39148724 Free PMC article. Review. - The dynamic role of platelets in cancer progression and their therapeutic implications.
Li S, Lu Z, Wu S, Chu T, Li B, Qi F, Zhao Y, Nie G. Li S, et al. Nat Rev Cancer. 2024 Jan;24(1):72-87. doi: 10.1038/s41568-023-00639-6. Epub 2023 Dec 1. Nat Rev Cancer. 2024. PMID: 38040850 Review. - The role of host response to chemotherapy: resistance, metastasis and clinical implications.
Deo A, Sleeman JP, Shaked Y. Deo A, et al. Clin Exp Metastasis. 2024 Aug;41(4):495-507. doi: 10.1007/s10585-023-10243-5. Epub 2023 Nov 24. Clin Exp Metastasis. 2024. PMID: 37999904 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical